ABSTRACT Of 120 consecutive balloon aortic valvuloplasty procedures for critical aortic stenosis, valvuloplasty was performed in combination with coronary angioplasty in nine patients (average age 76 years). All nine patients were symptomatic with angina and congestive heart failure before combined procedures. Aortic valvuloplasty was performed with 20 to 23 mm balloon catheters advanced retrogradely from the femoral artery and resulted in an improvement in peak aortic valve gradient (60 + 19 to 33 + 13 mm Hg; p ' .01) and calculated aortic valve area (0.7 + 0.1 to 1.1 + 0.3 cm2; p ' .01). Single-vessel coronary angioplasty was performed via the femoral approach, with 2.0 to 3.5 mm balloon catheters, and resulted in a mean reduction of a critical coronary stenosis in each patient from 91 + 4% to 29 + 8%. The site of coronary angioplasty was the left anterior descending artery in three patients, the circumflex artery in three patients, the right coronary artery in two patients, and a bypass graft to the right coronary artery in one patient. Combined procedures were performed with a mean arterial time of 108 min. Complications included groin hematomas (n = 2), transient left bundle branch block (n = 1), and transient atrial fibrillation (n = 1). No patient experienced prolonged chest pain, myocardial infarction, major increase in aortic insufficiency, or embolic phenomena. Eight of the nine patients treated with combined procedures noted significant improvement in symptoms of angina and congestive heart failure and were discharged. The ninth patient experienced persistent angina and was treated successfully with aortic valve replacement and coronary artery bypass grafting. Clinical follow-up at a mean of 6 months after procedure has revealed persistent clinical improvement in seven patients, with both valvular and coronary restenosis occurring in one patient. We conclude that combined percutaneous aortic valvuloplasty and coronary angioplasty may be performed safely in adult patients with calcific aortic stenosis and anatomically suitable, single-vessel coronary artery disease. This procedure may be useful in the treatment of selected patients who refuse or who are deferred from surgical intervention because of high operative risk. Circulation 76, No. 6, 1298-1306 SURGICAL MORTALITY for aortic valve replacement in patients with isolated aortic stenosis is in general quite low, ranging from 1% to 5%.1-6 The presence of coexisting coronary artery disease and the subsequent need for additional coronary artery bypass 
SURGICAL MORTALITY for aortic valve replacement in patients with isolated aortic stenosis is in general quite low, ranging from 1% to 5%.1-6 The presence of coexisting coronary artery disease and the subsequent need for additional coronary artery bypass grafting, however, may significantly raise the surgical risk, particularly in elderly patients.5 '6 In a recent report on 259 consecutive patients undergoing aortic valve replacement,6 overall operative mortality was 6 .9%, compared with 13.5% in patients undergoing aortic valve replacement combined with coronary artery bypass. Also of interest was the substantial increase in surgical risk for patients over 70 years of age, who had an operative mortality of 16.9%. Additional medical conditions such as congestive heart failure, pulmonary disease, and renal insufficiency may further raise the risk of surgical intervention.
Previous reports by our laboratory7'8 and others91- CIRCULATION have recently documented the utility of balloon aortic valvuloplasty as a palliative treatment for elderly patients with calcific aortic stenosis who refuse or who are deferred from aortic valve replacement. The efficacy of transluminal coronary angioplasty has likewise been documented in the elderly population.)2 13 The purpose of this study was to assess the potential utility of using both of these procedures in treating adult patients with combined valvular and coronary artery disease.
Methods
Study group. Combined aortic valvuloplasty and coronary angioplasty were performed in nine patients with critical, calcific aortic stenosis and coronary artery disease. The study group consisted of six women and three men with a mean age of 76 years (range 53 to 90). All patients were symptomatic with angina, dyspnea on exertion, and weakness. Angina was associated in all patients with transient electrocardiographic changes. Seven patients had a prior history ofpulmonary edema; in each case, pulmonary edema occurred after prolonged anginal episodes. Four patients had a prior history of a subendocardial myocardial infarction and continued to experience postinfarction angina with transient electrocardiographic changes in the area of their previous infarction. Two patients had previously undergone coronary artery bypass grafting. One patient was in atrial fibrillation, and the remainder were in normal sinus rhythm.
All patients were offered surgical intervention with an estimation oftheir operative risk, but refused surgery. Major reasons for deferring surgery included age greater than 80 years (n = 4), prior coronary artery bypass grafting (n = 2), and weakened and debilitated condition (n = 3).
Each patient subsequently elected to undergo combined balloon aortic valvuloplasty/coronary angioplasty after being informed of the tables 1 to 3) underwent two procedures, involving initial aortic valvuloplasty followed by coronary angioplasty 10 days later. In this patient, recurrent episodic weakness persisted after aortic valvuloplasty and subsequently improved after coronary angioplasty.
Each patient was brought to the cardiac catheterization laboratory where, after the administration of a local anesthetic, a left radial cannula was placed, the left femoral vein was instrumented with a No. 8F Hemaquet sheath (USCI), and the right femoral artery was instrumented with a No. 9F Hemaquet sheath. Right heart catheterization was performed from the left groin with a No. 7F flow-directed Pacewedge balloon-tipped catheter (Elecath). Continuous pulmonary artery and systemic arterial pressures were monitored throughout the course of the protocol. All patients were anticoagulated with 10,000 to 15,000 U of heparin intravenously, depending on the length of the procedure.
After placement of the right heart catheter, a No. 9F angioplasty guiding catheter (ACS) was passed from the right groin and used to engage the coronary or graft ostia; a No. 9F JR4 was used in the patients with a right coronary artery lesion and in the patient with a graft stenosis, and a No. 9F JL4 was used in the patients with either left anterior descending or circumflex lesions. In each patient, a 0.018 inch high-torque floppy guidewire (ACS) was advanced into the coronary artery past the coronary stenosis, followed by placement of a 2.0 to 3.0 mm Simpson-Robert angioplasty catheter (ACS) at the site of the coronary stenosis. After initial dilatation of the coronary stenosis, a 0.018 inch exchange wire was used to replace the hightorque floppy guidewire, the angioplasty catheter was withdrawn, and repeat coronary angiography was performed. Additional inflations with larger balloon sizes were performed if necessary until the coronary stenosis had been dilated to less than a 50% residual. The angioplasty catheters and guidewires were then withdrawn and repeat coronary injections were made over a period of Serial systolic time intervals were also obtained in each patient at the time of their echocardiographic study with an Irex System II M mode echocardiograph equipped with capability for phonocardiographic and pulse-tracing studies. The time to onehalf carotid upstroke was measured as the time (msec) from the initial rapid upstroke of the carotid pulse to the point at which it had attained one-half its peak amplitude. The left ventricular ejection time was measured as the time (sec) from the initial rapid upstroke of the carotid pulse to the trough of the dicrotic notch, with appropriate correction made for heart rate.
Doppler assessment of aortic insufficiency and mitral regurgitation was determined before and after the procedure with the ATL equipment. Aortic insufficiency was graded simply as either present or absent; in a patient in whom aortic insufficiency was present before valvuloplasty, this technique could not be used to accurately quantify increases in the magnitude of aortic regurgitation that were caused by the valvuloplasty. Mitral regurgitation was classified as absent, mild, moderate, or severe, depending on the extension of the signal of mitral regurgitation from the mitral leaflets to the back wall of the left atrium.8
Statistics. Means Coronary angiography revealed the presence of single-vessel coronary artery disease in all nine patients, including three patients with a stenosis in the left anterior descending artery, three patients with a stenosis in the left circumflex artery, two patients with a stenosis in the right coronary artery, and one patient with a stenosis in a graft to the right coronary artery. The right coronary artery was dominant in seven of the nine patients; the left coronary artery was dominant in two of the three patients with circumflex stenoses. In the four patients with a history of a myocardial infarction, the coronary stenosis was located in the distribution of the previous infarction. In the two patients with prior coronary artery bypass surgery, bypass grafts were patent in one patient and a new stenosis had developed in the native circulation, whereas in the second patient a graft stenosis had developed without progression of disease in the native circulation.
Angioplasty results. Angioplasty was accomplished successfully in all nine patients with 2.0 to 3.5 mm balloons. The largest angioplasty balloon used was a 2.0 mm balloon in two patients, a 2.5 mm balloon in two patients, a 3.0 mm balloon in three patients, and a 3.5 mm balloon in two patients. A single stenosis was dilated in all patients with a mean change in percent stenosis from 91 ± 4% to 29 ± 8%. Moderate dissection was noted at the site of the dilatation in three of the nine patients but did not interfere with antegrade flow. Angiographic findings before and after angioplasty are summarized in table 2.
CIRCULATION 1300 tion, followed by return of these pressures to baseline immediately after inflation. All patients experienced runs of ventricular tachycardia during valvuloplasty balloon inflation, but no patient required cardioversion. No procedure was complicated by embolic phenomenon, hemodynamic evidence of acute aortic insufficiency, prolonged chest pain, or evidence of myocardial infarction. One patient developed a transient left bundle branch block, which disappeared 12 hr after the procedure. A second patient developed atrial fibrillation during aortic valve dilatation, which resolved spontaneously within 3 hr. Two patients developed moderate groin hematomas at the site of arterial puncture and required transfusion. Figure 1 bypass grafting were successfully performed and her condition subsequently improved.
The remaining eight patients all noted major improvement in symptoms of angina, dyspnea on exertion, and weakness and were discharged from the hospital. One patient (No. 1, tables 1 to 3) noted recurrent symptoms of angina and heart failure 4 months after the procedure. Repeat cardiac catheterization demonstrated restenosis of both her aortic valve and her right coronary artery, and the patient elected to undergo surgery, which was performed successfully. The remaining patients have all done well without recurrent symptoms. At a mean follow-up of 6 months (range 2 to 9), six patients are totally asymptomatic and one patient still experiences mild, infrequent angina.
Discussion
This study demonstrates that combined percutaneous coronary angioplasty and balloon aortic valvuloplasty can be carried out safely in adult patients with both critical aortic stenosis and single-vessel coronary artery disease. Successful reduction of coronary stenoses to less than 50% was achieved in all patients, and significant improvement in aortic valve area was achieved in eight of the nine patients. Combined artery and valve dilatation in this study group have thus far resulted in short-term palliation of symptoms of angina and congestive heart failure in a majority of patients.
A nonsurgical alternative for high-risk patients. Improvements in intraoperative methods of myocardial preservation as well as advancements in preoperative and postoperative management have significantly decreased the operative risk of aortic valve replacement 1303 in the last two decades.'-6 Recent studies cite a mortality of 1% in patients under 70 years of age with isolated aortic stenosis who undergo elective 6 surgery. Increases in surgical risk, however, have been documented in elderly patients, in patients with coronary artery disease requiring bypass grafting, in patients with congestive heart failure, and in patients with associated medical conditions, including renal insufficiency, pulmonary dysfunction, and malignancy.
As a possible nonsurgical alternative, aortic valvuloplasty has recently been documented as a new modality for treating high-risk surgical patients with critical aortic stenosis.7-' The procedure has been shown to produce at least short-term hemodynamic improvement, including improvement in cardiac output, left ventricular filling pressures, and left ventricular ejection fraction.8 The long-term effect and overall utility of valvuloplasty, however, are currently being determined. Preliminary reports suggest at least favorable palliation of symptoms 6 months after valve dilatation. 14 Over the last decade, percutaneous coronary angioplasty has likewise become accepted as an alternative nonsurgical mode of therapy for coronary artery disease. Elderly patients, in particular, represent a subgroup in whom the risk of surgery is higher and in whom a less invasive procedure is attractive. Several large studies have documented the safety and clinical efficacy of coronary angioplasty in elderly patients.", 1 Given the existence of a high-risk surgical population, the proven efficacy of coronary angioplasty in elderly patients, and the promising early results of valvuloplasty studies, it is possible that combined valvuloplasty/angioplasty procedures will be an effective palliative technique for treating selected patients deferred from surgery. A true assessment of the utility of the technique will require a large clinical trial comparing surgery to valvuloplasty/angioplasty and will need to address the actual incidence of coronary and valvular restenosis.
Interpretation of aortic valvuloplasty results. The hemodynamic results after aortic valvuloplasty that are reported for the nine patients in this study group are typical of the heterogeneous results that have been previously reported for this technique. 8 It is notable, for example, that three of the nine patients demonstrated only small increases in aortic valve area (patients 2, 3, nied by a transient fall in arterial pressure during balloon inflation and since this hypotension could potentially lead to severe myocardial ischemia in the presence of a critical coronary stenosis and an abrupt increase in left ventricular systolic pressure, it may be argued that angioplasty should precede valvuloplasty. In this study, angioplasty was performed before aortic valve dilatation due largely to technical factors concerning balloon size: angioplasty was performed through a No. 9F sheath, whereas valvuloplasty required femoral arterial dilatation with a No. 12F dilator. To minimize blood loss during the procedure, we began with the procedure requiring the smaller sheath. If technical improvements in the manufacture of valvuloplasty catheters result in smaller-profile balloon catheters capable of insertion through smaller sheaths, it will be possible to assess in a prospective fashion the preferred order of valve/artery dilatation.
A major technical factor related to aortic valvuloplasty that at present is unknown is the maximum diameter of valvuloplasty balloon that can safely be used to dilate an aortic valve. Postmortem work from our laboratory15 has suggested that a 20 mm balloon could successfully dilate most specimens without damage to the aortic ring or aortic leaflets but that overdistension of the aortic anulus with a 25 mm balloon could result in leaflet avulsion. To date, the maximum balloon size that has been used clinically in our laboratory has been 23 mm; this balloon has been used only if the 20 mm balloon was undersized for the patient, as evidenced by excessive motion of the inflated balloon in the aortic valve and minimal fall in arterial blood pressure during balloon inflation. It is for this reason that 23 mm balloons were not used in some patients in the present study in spite of high residual postvalvuloplasty aortic gradients.
Although angioplasty/valvuloplasty procedures reported in this study were performed as a single procedure, it is also possible that continued investigation will indicate that these two procedures should be performed separately as staged procedures. Of notable. First, the study group is small and the combined angioplasty/valvuloplasty approach that was chosen for this group may not be applicable for the majority of patients with combined aortic stenosis and coronary artery disease. Of note, of the 120 consecutive patients that have undergone aortic valvuloplasty at our hospital, over one-third had coexistent coronary disease. The nine patients in the present study were chosen from this larger group of patients because they had only single-vessel coronary artery disease, their coronary lesions were suitable for angioplasty, and angina was a major complaint. The remaining patients were not treated with angioplasty because their coronary disease was too extensive (i.e., multivessel or left main disease) and/or angina was not a major complaint; in these patients, aortic valvuloplasty was performed alone and coronary disease was treated with medical therapy. A second reason why this study may not be generally applicable to the treatment of patients with combined aortic stenosis and coronary artery disease is because of the potential complications associated both with angioplasty and valvuloplasty. With respect to angioplasty, although several studies have confirmed the efficacy of this procedure in elderly patients, it should be noted that when complications occur in this subgroup of patients the consequences are usually more severe, with a higher mortality in elderly patients compared with younger patients. Similarly, although no major valvuloplasty complications occurred in this study group, all preliminary studies on this technique have reported major life-threatening complications. Only with continued investigation will the safety and overall efficacy of aortic valvuloplasty be established.
Conclusions. Combined balloon aortic valvuloplasty and coronary angioplasty was performed in nine patients with calcific aortic stenosis and coronary artery disease. Reduction of coronary stenoses to less than 50% was achieved in all nine patients, whereas significant improvement in aortic valve area was achieved in eight patients, with postvalvuloplasty aortic valve areas greater than or equal to 1.0 cm2 in six. All nine patients were elderly (eight were over 70 years of age), had prominent angina as well as congestive heart failure, and would have had an increased predicted operative mortality based on recent surgical reports.5 6 Results of follow-up averaging 6 
